Globally, ACRII inhibitors have shown promise in promoting muscle gain and could potentially be combined with GLP-1
What Is Peripheral Neuropathy
When used together, the products were reported to promote more GLP-1 receptor sites and reduce an enzyme that breaks down GLP-1 by 38 percent
But how does it actually work
In a BPC-157 and TB-500 stack, it is common to keep the BPC-157 dose at the standard 250-500 mcg range, as its action is highly localized, but reduce the TB-500 dose to the lower end of the range (e.g., 2.5 mg per week) for systemic support
Just 4 weeks ago, the big peptide vendors, Peptide Sciences, got shot down, and now Amazon has taken down BAC water, which plays an important role in the research